Impact Biomedical to execute 1-for-12.62 reverse stock split Sept. 23 - IBO News | RalliesImpact Biomedical to execute 1-for-12.62 reverse stock split Sept. 23
I
IBO• Reverse stock split and share count
- Impact Biomedical set a 1-for-12.62 reverse stock split, effective Sept. 23, 2026.
- Shares will continue trading on NYSE American under IBO.
- Outstanding shares are expected to drop to about 8,543,679 from about 107,821,231, subject to rounding.
- Merger terms with Zoar call for 1 Zoar share per 1 Impact share, calculated post-split.
